Häftad, Engelska, 2019

Resistance to Ibritumomab in Lymphoma

Av Makoto Hosono, Jean-François Chatal

Del 18 i serien Resistance to Targeted Anti-Cancer Therapeutics

1114 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

Produktinformation

Utgivningsdatum: 2019-01-08
Mått: 155 x 235 x 10 mm
Vikt: 271 g
Format: Häftad
Språk: Engelska
Serie: Resistance to Targeted Anti-Cancer Therapeutics
Antal sidor: 158
Förlag: Springer Nature Switzerland AG
ISBN: 9783030086527

Utforska kategorier

Onkologi

Mer om författaren

Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection. Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.